Jørgensen H, Knigge U, Kjaer A, Warberg J
Department of Medical Physiology, Panum-Institute, University of Copenhagen, Denmark.
Neuroendocrinology. 1996 Nov;64(5):329-36. doi: 10.1159/000127136.
Serotonergic and histaminergic neuronal systems are both involved in mediation of the stress-induced release of the pituitary hormones prolactin (PRL) and ACTH. We investigated the possibility of an interaction between serotonin (5-HT) and histamine (HA) in regulation of PRL and ACTH secretion in conscious male rats. Animals were pretreated systemically with antagonists to 5-HT1, 5-HT2 or 5-HT3 receptors prior to intracerebroventricular (icv) administration of HA. The 5-HT1 + 2 receptor antagonist methysergide prevented and the 5-HT2 receptor antagonist LY 53857 attenuated the HA-induced PRL release while the 5-HT3 receptor antagonist ondansetron had no effect on this response. None of the three 5-HT receptor antagonists affected the ACTH response to HA. Specific blockade of HA synthesis by alpha-fluoromethylhistidine or blockade of postsynaptic HA receptors by icv infusion of the H1 receptor antagonist mepyramine or the H2 receptor antagonist cimetidine inhibited the PRL response to 5-HT or to the 5-HT precursor 5-hydroxytryptophan (5- HTP) given in combination with the 5-HT reuptake inhibitor fluoxetine (Flx). Blockade of the histaminergic system had no effect on the ACTH response to serotonergic stimulation. The H3 receptors are inhibitory HA receptors. Systemic pretreatment with the H3 receptor agonist R(alpha)methylhistamine, or the H3 receptor antagonist thioperamide had no effect on the hormone response to activation of the serotonergic system by 5-HTP plus Flx. We conclude that the serotonergic and histaminergic neuronal systems interact in their stimulation of PRL secretion, but not in their stimulation of ACTH secretion. This interaction involves serotonergic 5-HT1 and 5-HT2 receptors and histaminergic H1 and H2 receptors. Furthermore, the previously observed inhibitory effect of the H3 receptor agonist R(alpha)methylhistamine on stress-induced PRL and ACTH release seems not to be exerted by activation of presynaptic H3 receptors located on serotonergic neurons but rather on histaminergic neurons.
5-羟色胺能和组胺能神经系统均参与介导应激诱导的垂体激素催乳素(PRL)和促肾上腺皮质激素(ACTH)的释放。我们研究了5-羟色胺(5-HT)与组胺(HA)在调节清醒雄性大鼠PRL和ACTH分泌过程中相互作用的可能性。在脑室内(icv)给予HA之前,先对动物进行全身性预处理,使用5-HT1、5-HT2或5-HT3受体拮抗剂。5-HT1 + 2受体拮抗剂麦角酰二乙胺可阻止HA诱导的PRL释放,5-HT2受体拮抗剂LY 53857可减弱该反应,而5-HT3受体拮抗剂昂丹司琼对该反应无影响。三种5-HT受体拮抗剂均不影响ACTH对HA的反应。α-氟甲基组胺特异性阻断HA合成,或icv注入H1受体拮抗剂美吡拉敏或H2受体拮抗剂西咪替丁阻断突触后HA受体,均抑制PRL对5-HT或对与5-HT再摄取抑制剂氟西汀(Flx)联合给予的5-HT前体5-羟色氨酸(5-HTP)的反应。组胺能系统的阻断对ACTH对5-羟色胺能刺激的反应无影响。H3受体是抑制性HA受体。用H3受体激动剂R(α)甲基组胺或H3受体拮抗剂硫代哌啶进行全身性预处理,对5-HTP加Flx激活5-羟色胺能系统所引起的激素反应无影响。我们得出结论,5-羟色胺能和组胺能神经系统在刺激PRL分泌方面相互作用,但在刺激ACTH分泌方面不相互作用。这种相互作用涉及5-羟色胺能5-HT1和5-HT2受体以及组胺能H1和H2受体。此外,先前观察到的H3受体激动剂R(α)甲基组胺对应激诱导的PRL和ACTH释放的抑制作用似乎不是通过激活位于5-羟色胺能神经元上的突触前H3受体,而是通过激活组胺能神经元上的突触前H3受体来发挥作用的。